Stock listing
NASDAQ:PDLI PDL BioPharma Inc Stock
Follow PDL BioPharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PDLI
$2.47 USD
Close on Jan 6, 2021 · No longer trades
- Lowest – highest close
- $1.98 – $40.57 USDSince Oct 10, 2001 · lowest Dec 20, 2016 · highest Dec 6, 2001
Delisted NASDAQ:PDLI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PDLI
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
PDL BioPharma Inc on 6ix
- Decks
- 130 decks · latest Nov 13, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2020 Earnings Presentation | Earnings | 13 slides | Nov 13, 2020 |
| Investor Presentation (September 2020) | Investor deck | 32 slides | Sep 10, 2020 |
| Q2 2020 Earnings Presentation | Earnings | 17 slides | Aug 6, 2020 |
| Investor Presentation (July 2020) | Investor deck | 30 slides | Jul 17, 2020 |
| Q1 2020 Earnings Presentation | Earnings | 15 slides | May 7, 2020 |
| Q4 2019 Earnings Presentation | Earnings | 16 slides | Mar 11, 2020 |
| Proxy Contest (January 2020) | Proxy contest | 19 slides | Jan 15, 2020 |
| Q3 2019 Earnings Presentation | Earnings | 14 slides | Nov 6, 2019 |
| Investor Presentation (October 2019) | Investor deck | 30 slides | Oct 21, 2019 |
| Cantor Fitzgerald Global Healthcare Conference 2019 | Conference | 26 slides | Oct 3, 2019 |
Show 50 decks
This page holds 50 of 130 decks. Open Decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David W. Gryska Other companies: Celcuity Inc. (Director · Since at least Oct 1, 2026); Definium Therapeutics, Inc. (Audit · Since at least Jun 21, 2023); Forte Biosciences, Inc. (Director · Since at least Jan 10, 2023); GW Pharmaceuticals plc (Director · Sep 9, 2020 – May 5, 2021 · Past); Incyte Corporation (Executive Vice President, CFO · Oct 31, 2014 – Jul 16, 2018 · Past); Argos Therapeutics Inc (Director · Feb 6, 2014 – Feb 6, 2014 · Past); Aerie Pharmaceuticals Inc. (Director · Oct 25, 2013 – Nov 21, 2022 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – Apr 15, 2013 · Past); Myrexis Inc (Chief Operating Officer, Director · May 11, 2012 – May 11, 2012 · Past); Celgene Corporation (Chief Financial Officer · Dec 6, 2006 – Jul 13, 2010 · Past); Seagen Inc (Director · Feb 14, 2006 – Dec 14, 2023 · Past) | Director · Mar 6, 2014 – Dec 30, 2020 · Past |
| Faheem Hasnain Other companies: Aspen Neuroscience, Inc. (Aspen Executive Chairman · Since at least Nov 2, 2026); Gossamer Bio, Inc. (Co-Founder, Chairman, and Chief Executive Officer · Since at least Feb 7, 2019); Kura Oncology, Inc. (Lead Independent Director · Since at least Apr 23, 2015); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Immunic, Inc. (Director · Aug 11, 2016 – Sep 13, 2018 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – Nov 10, 2014 · Past); Receptos Inc (President & CEO, Director · May 8, 2013 – Aug 25, 2015 · Past); Somaxon Pharmaceuticals Inc (Director · Sep 16, 2010 – Dec 31, 2012 · Past); Facet Biotech Corp (President & CEO, Director · Dec 9, 2008 – Apr 21, 2010 · Past) | President & CEO, Director · Oct 1, 2008 – Oct 1, 2008 · Past |
| Alan Bazaar Other companies: Fox Factory Holding Corp. (Director · Since at least Feb 13, 2026); Orthofix Medical Inc. (Director · Since at least Dec 12, 2023); Sparton Corporation (Director · May 4, 2016 – Mar 4, 2019 · Past); Star Equity Holdings, Inc. (Director · Jun 15, 2015 – Mar 15, 2019 · Past); LoJack Corp (Director · Mar 24, 2015 – Mar 15, 2016 · Past); Wireless Telecom Group Inc (Director · Jun 12, 2013 – Aug 4, 2023 · Past); NTS Inc (Director · Dec 20, 2012 – May 8, 2013 · Past); Media Sciences International Inc (Director · Jan 30, 2006 – Jan 30, 2006 · Past) | Director · Apr 17, 2020 – Nov 18, 2020 · Past |
| Herb Cross Other companies: Jasper Therapeutics, Inc. (Chief Financial Officer · Since at least Sep 22, 2023); Apexigen Inc. (Director · Jul 29, 2022 – Aug 23, 2023 · Past); Atreca Inc (Chief Financial Officer · Jun 19, 2019 – Aug 2, 2023 · Past); Armo Biosciences Inc. (Chief Financial Officer · Jan 25, 2018 – Jun 22, 2018 · Past); Humanigen Inc (Chief Financial Officer · Oct 22, 2013 – Nov 9, 2015 · Past); Affymax Inc (Chief Financial Officer · Nov 15, 2010 – Jan 30, 2013 · Past); Facet Biotech Corp (VP of Finance · Dec 9, 2008 – Apr 21, 2010 · Past); Neoforma Inc (VP of Finance · Dec 31, 2005 – Dec 31, 2005 · Past) | Corp Controller/Prin Acctg Off · Jun 20, 2007 – Sep 15, 2008 · Past |
| Shlomo Yanai Other companies: Philip Morris International Inc (Director · Since at least May 5, 2021); Amneal Pharmaceuticals, Inc. (Director · Since at least Dec 14, 2019); W. R. Grace & Co (Director · May 9, 2018 – Sep 22, 2021 · Past); Exela Technologies, Inc. (Director · Jul 12, 2017 – Jul 12, 2017 · Past); Perrigo Company plc (Director · Nov 4, 2015 – May 19, 2016 · Past); Sagent Pharmaceuticals Inc (Director · Apr 15, 2015 – Aug 29, 2016 · Past); Protalix BioTherapeutics, Inc. (de) (Director · Jul 24, 2014 – Jul 24, 2014 · Past); Cambrex Corporation (Director · Nov 28, 2012 – Dec 4, 2019 · Past) | Director · Jun 8, 2018 – Jun 20, 2019 · Past |
| Paul Edick Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Oct 27, 2025); Xeris Biopharma Holdings, Inc. (See Remarks, Director · Oct 5, 2021 – Jan 31, 2024 · Past); Milestone Pharmaceuticals Inc. (Director · May 8, 2019 – Jun 5, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Aug 1, 2016 – Feb 13, 2018 · Past); Neos Therapeutics Inc (Director · Jul 22, 2015 – Jul 3, 2017 · Past); Durata Therapeutics Inc (Chief Executive Officer, Director · Mar 15, 2012 – Nov 17, 2014 · Past); Lumos Pharma Inc (Director · Nov 10, 2011 – May 12, 2017 · Past) | Director · Sep 3, 2015 – Jun 8, 2018 · Past |
| Samuel R Saks Other companies: Protagonist Therapeutics, Inc. (Chief Medical Officer · May 21, 2018 – Feb 26, 2021 · Past); Auspex Pharmaceuticals Inc (Chief Development Officer, Director · Feb 4, 2014 – May 5, 2015 · Past); Tonix Pharmaceuticals Holding Corp. (Director · Jan 14, 2013 – Jun 12, 2018 · Past); Depomed Inc (Director · Oct 8, 2012 – May 18, 2016 · Past); Cougar Biotechnology Inc (Director · Sep 12, 2007 – Jul 3, 2009 · Past); Jazz Pharmaceuticals plc (Chief Executive Officer, Director · May 31, 2007 – Jan 21, 2009 · Past); Trubion Pharmaceuticals Inc (Director · Oct 17, 2006 – Oct 28, 2010 · Past) | Director · Sep 14, 2015 – Jun 20, 2019 · Past |
| Joseph Klein III Other companies: Ionis Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2006); Akcea Therapeutics Inc (Director · Sep 20, 2019 – Oct 12, 2020 · Past); BioMarin Pharmaceutical Inc. (Director · Jun 28, 2006 – Mar 8, 2010 · Past); Osi Pharmaceuticals Inc (Director · Jun 14, 2006 – Jun 8, 2010 · Past); Savient Pharmaceuticals Inc (Director · May 23, 2006 – Jun 8, 2010 · Past); NPS Pharmaceuticals Inc (Director · Jan 17, 2006 – May 22, 2007 · Past) | Director · Jul 28, 2007 – Nov 4, 2009 · Past |
| Andrew Guggenhime Other companies: Caribou Biosciences, Inc. (President and Chief Financial Officer · Since at least Jul 22, 2021); Vaxcyte, Inc. (PRESIDENT AND CFO · Since at least Jun 11, 2020); Metacrine Inc (Director · Sep 15, 2020 – May 18, 2022 · Past); Facet Biotech Corp (SVP & CFO · Dec 9, 2008 – Apr 21, 2010 · Past); Neoforma Inc (Chief Financial Officer · Dec 31, 2005 – Dec 31, 2005 · Past) | SVP & Chief Financial Officer · Apr 3, 2006 – Dec 18, 2008 · Past |
| John Peter McLaughlin Other companies: LENSAR, Inc. (Director · Sep 17, 2020 – May 25, 2023 · Past); Rockwell Medical, Inc. (Director · Sep 5, 2019 – Jun 17, 2021 · Past); Adverum Biotechnologies Inc (Director · Jul 30, 2014 – Feb 12, 2016 · Past); Seagen Inc (Director · Jun 13, 2007 – May 20, 2016 · Past); Anesiva Inc (Chief Executive Officer, Director · May 10, 2006 – Feb 7, 2008 · Past) | Director · Oct 8, 2008 – Dec 21, 2020 · Past |
All 41 people
| Person | Seat |
|---|---|
| Jon S. Saxe Other companies: Vistagen Therapeutics, Inc. (Chair of the Board · Since at least May 11, 2011); Durect Corporation (Director · Jun 20, 2006 – Jun 17, 2020 · Past); Sciele Pharma Inc (Director · Jun 15, 2006 – May 23, 2008 · Past); SciClone Pharmaceuticals Inc (Director · Jun 13, 2006 – Oct 13, 2017 · Past); Questcor Pharmaceuticals Inc (Director · Jan 1, 2006 – Jan 1, 2006 · Past) | Director · Jan 4, 2006 – Apr 9, 2008 · Past |
| Mark McDade Other companies: Tourmaline Bio Inc. (Director · Since at least May 6, 2021); Icosavax Inc (Director · Apr 1, 2022 – Jun 6, 2023 · Past); Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past); Five Prime Therapeutics Inc (Director · Sep 17, 2013 – May 10, 2018 · Past); Cytokinetics, Incorporated (Director · May 25, 2006 – May 21, 2009 · Past) | CEO, Director · Jan 3, 2006 – Jul 20, 2007 · Past |
| Max Link Other companies: BioSpecifics Technologies Corp (Director · Aug 4, 2014 – Aug 4, 2014 · Past); SiNtx Technologies, Inc. (Director · Feb 12, 2014 – Aug 12, 2014 · Past); Human Genome Sciences Inc (Director · Apr 27, 2006 – Apr 11, 2008 · Past); Imunon, Inc. (Director · Mar 15, 2006 – Jun 20, 2014 · Past); Alexion Pharmaceuticals Inc (Director · Jan 9, 2006 – May 5, 2014 · Past) | Director · Jun 14, 2006 – Nov 30, 2006 · Past |
| Elizabeth G. O’Farrell Other companies: SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); LENSAR, Inc. (Director · Since at least Feb 1, 2021); Geron Corporation (Director · Since at least Mar 26, 2019); Inhibikase Therapeutics, Inc. (Director · Dec 22, 2020 – Jun 24, 2022 · Past) | Director · Jun 22, 2018 – Nov 23, 2020 · Past |
| Francis Willard Sarena Other companies: 89bio Inc (Chief Operating Officer · Since at least Jul 30, 2024); Apexigen Inc. (President and COO · Jul 29, 2022 – Aug 23, 2023 · Past); Five Prime Therapeutics Inc (Chief Strategy Officer · Sep 17, 2013 – Apr 1, 2021 · Past); Facet Biotech Corp (VP Gen Counsel & Secy · Dec 9, 2008 – Apr 21, 2010 · Past) | VP/Gen Counsel/Secy · Jan 10, 2008 – Sep 15, 2008 · Past |
| Harold E. Barry Selick Other companies: Protagonist Therapeutics, Inc. (Chairman, Independent Director, Hinge Bio, Inc. · Since at least Aug 10, 2016); Molecular Templates Inc (Director · Oct 9, 2017 – Sep 27, 2024 · Past); Gyre Therapeutics, Inc. (Director · Aug 20, 2015 – Jan 16, 2018 · Past); Threshold Pharmaceuticals Inc (Chief Executive Officer, Director · Mar 14, 2006 – Mar 14, 2016 · Past) | Director · Aug 1, 2009 – Jun 20, 2019 · Past |
| Jaisim Shah Other companies: Semnur Pharmaceuticals, Inc. (See Remarks, Director · Since at least Sep 22, 2025); Scilex Holding Company (See Remarks, Director · Nov 10, 2022 – Dec 18, 2024 · Past); Sorrento Therapeutics, Inc. (Director · Sep 9, 2013 – Aug 30, 2021 · Past); Facet Biotech Corp (SVP, Chief Business Officer · Dec 9, 2008 – Dec 9, 2008 · Past) | SVP, Mktg & Bus. Affairs · Jan 9, 2006 – Apr 28, 2008 · Past |
| Mark Anthony McCamish Other companies: Avadel Pharmaceuticals PLC (Director · Since at least Dec 5, 2019); Rafael Holdings, Inc. (Director · Jun 14, 2021 – Jan 5, 2024 · Past); Forty Seven Inc (President and CEO, Director · Jun 27, 2018 – Apr 7, 2020 · Past); Facet Biotech Corp (Sr. VP & Chief Medical Officer · Dec 9, 2008 – Apr 2, 2009 · Past) | SVP & CMO · Feb 21, 2007 – Dec 18, 2008 · Past |
| Karen A Dawes Other companies: Repligen Corporation (Director · Since at least Sep 1, 2006); Vaccitech plc (Director · Apr 29, 2021 – May 11, 2023 · Past); Depomed Inc (Director · Apr 8, 2008 – May 8, 2018 · Past) | Chairperson of the Board, Director · Jun 14, 2006 – Apr 29, 2008 · Past |
| Natasha Hernday Other companies: XOMA Royalty Corporation (Director · Since at least May 21, 2025); Janux Therapeutics, Inc. (Director · Since at least Jul 19, 2024); Alpine Immune Sciences Inc (Director · Dec 10, 2020 – May 20, 2024 · Past) | Director · Jun 20, 2019 – Aug 19, 2020 · Past |
| Peter S Garcia Other companies: Durect Corporation (Director · Since at least Dec 13, 2021); ALX Oncology Holdings Inc. (CHIEF FINANCIAL OFFICER · Jul 16, 2020 – Aug 14, 2024 · Past); Lineage Cell Therapeutics, Inc. (Chief Financial Officer · Oct 3, 2011 – Feb 20, 2013 · Past) | Vice President, CFO · May 16, 2013 – Mar 28, 2019 · Past |
| Steffen Pietzke Other companies: Enovix Corporation (Chief Financial Officer · Jul 14, 2021 – Jul 6, 2023 · Past); ALX Oncology Holdings Inc. (VP Fin & Chief Acct Officer · Jul 16, 2020 – Jul 21, 2020 · Past); Tricida Inc (VP Fin & Chief Acct Officer · Jun 27, 2018 – Feb 24, 2020 · Past) | VP, Finance and CAO · Jun 24, 2015 – Dec 15, 2017 · Past |
| Dominique Monnet Other companies: Evofem Biosciences, Inc. (Director · Jun 10, 2019 – Jun 10, 2019 · Past); Alexion Pharmaceuticals Inc (SVP, Chief Marketing Officer · Feb 2, 2015 – May 20, 2015 · Past) | President and CEO · Sep 11, 2017 – Dec 16, 2020 · Past |
| Fred Frank Other companies: Lifecore Biomedical, Inc. (Director · Jun 15, 2006 – Oct 14, 2020 · Past); Pharmaceutical Product Development Inc (Director · Jan 3, 2006 – Dec 5, 2011 · Past) | Director · Mar 11, 2009 – Jun 5, 2012 · Past |
| L Patrick Gage Other companies: Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Jul 28, 2020 · Past); Cytokinetics, Incorporated (Director · Nov 5, 2009 – Nov 8, 2021 · Past) | Interim CEO, Director · Jun 14, 2006 – Apr 28, 2008 · Past |
| Maninder Hora Other companies: Nektar Therapeutics (SVP Pharma Dev & Mfg Ops · Apr 4, 2012 – May 16, 2019 · Past); Facet Biotech Corp (VP, Prod Ops. & Quality · Dec 9, 2008 – Apr 21, 2010 · Past) | VP of Product Operations · Aug 13, 2008 – Aug 13, 2008 · Past |
| Christine R Larson Other companies: Dynavax Technologies Corporation (VP and Chief Financial Officer · Aug 13, 2012 – Aug 13, 2012 · Past) | Vice President and CFO · Dec 18, 2008 – May 23, 2011 · Past |
| Jill M. Jene Other companies: Lipocine Inc. (Director · Since at least Apr 11, 2022) | VP, Business Development · Jun 8, 2018 – Jan 8, 2020 · Past |
| Jody S Lindell Other companies: The Cooper Companies, Inc. (Director · Mar 21, 2006 – Jan 6, 2023 · Past) | Director · Mar 11, 2009 – Jun 8, 2018 · Past |
| Richard /CA/ Murray Other companies: Jounce Therapeutics Inc (Director · Jan 26, 2017 – May 3, 2023 · Past) | EVP & CSO · Mar 3, 2006 – Jul 21, 2008 · Past |
| Steven E Benner Other companies: CTi Biopharma Corp (EVP, Chief Medical Officer · Jun 13, 2012 – Mar 21, 2013 · Past) | SVP & Chief Med. Off. · Jul 16, 2006 – Jul 20, 2006 · Past |
| Bruce Tomlinson | Chief Financial Officer · Jun 11, 2012 – Jun 21, 2012 · Past |
| Caroline J Krumel | VPFinance/Prin.Accting Officer · Jan 31, 2011 – Jan 18, 2012 · Past |
| Christopher Lewis Stone | VP, Gen. Counsel & Secretary · Feb 2, 2009 – Dec 16, 2020 · Past |
| David Iwanicki | VP, Sales & Sales Operations · Jul 13, 2005 – Jan 2, 2008 · Past |
| David Montez | Controller and CAO · Jul 29, 2013 – Jan 28, 2015 · Past |
| Edward Imbrogno | VP Finance, CAO and Acting CFO · Jun 20, 2019 – Feb 7, 2020 · Past |
| Laurence Jay Korn | Director · Jan 3, 2006 – May 28, 2008 · Past |
| Laurie C Torres | VP, Corporate Services · Jan 4, 2006 – Apr 13, 2007 · Past |
| Paul W Sandman | Director · Jun 8, 2018 – Jun 20, 2019 · Past |
| Peter H Calcott | VP, Quality & Compliance · Jul 5, 2006 – Jan 5, 2007 · Past |
Log in to ask 6ix AI your own questions about PDL BioPharma Inc.